Sarepta Therapeutics | 4:持股變動聲明-高管 Rodino-Klapac Louise
Sarepta Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Janus Henderson Group plc(4.6%)
Sarepta Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Capital International Investors(6.7%)
Sarepta Therapeutics | 10-Q:2024財年三季報
Sarepta Therapeutics | 4:持股變動聲明-董事 Connelly Deirdre P
Sarepta Therapeutics | 3:首次持股聲明-董事 Connelly Deirdre P
Sarepta Therapeutics | 8-K:重大事件
Sarepta Therapeutics | 4:持股變動聲明-董事 BEHRENS M KATHLEEN
Sarepta Therapeutics | 4:持股變動聲明-高管 Estepan Ian Michael
Sarepta Therapeutics | 144:擬議出售證券
Sarepta Therapeutics | 4:持股變動聲明-董事 Chambers Michael Andrew
Sarepta Therapeutics | S-8:員工福利計劃證券登記
Sarepta Therapeutics | 10-Q:2024財年二季報
Sarepta Therapeutics | 4:持股變動聲明-董事 BEHRENS M KATHLEEN
Sarepta Therapeutics | 4:持股變動聲明-高管 Brown Ryan Edward
Sarepta Therapeutics | 4:持股變動聲明-高管 Rodino-Klapac Louise
Sarepta Therapeutics | 4:持股變動聲明-高管 Murray Dallan
Sarepta Therapeutics | 4:持股變動聲明-高管 Estepan Ian Michael
Sarepta Therapeutics | 4:持股變動聲明-高管 Arif Bilal
Sarepta Therapeutics | 144:擬議出售證券
暫無數據
暫無數據